Tablets 1mg, 5mg
e/c tablets 2.5mg

First line oral corticosteroid treatment.

25mg tablets are classified as Do Not Prescribe.

There is no evidence that e/c prednisolone reduces the risk of gastrointestinal side effects. Uncoated 5mg tablets should be prescribed first line together with a PPI if necessary.

Foam 20mg/metered application,
Retention enema 20mg/100mL,
Suppositories 5mg

Prednisolone foam enema and suppositories only to be used if documented non-response on prescription to first line budesonide preparation, otherwise prescription must be challenged.

First line rectal treatment (foam enema)

Capsules 3mg, Enema

Modified release capsules 4mg (targeted release)

For treating primary IgA nephropathy in accordance with NICE TA937

Tablets, M/R 9 mg